$heff's $tation of $tocks & $olid DD

[rocketeer357]

EXEL offering priced at $4.25 for the common, convertible priced at $5.31.

http://ih.advfn.com/p.php?pid=nmona&article=53768821&symbol=EXEL

This deal closes (hopefully) on 14 August. The company then has better than 1/2 a billion in cash on its books, looking at FDA approval in late November. That should take care of the cash needs for a while, (but then again, that's what I thought when they had 200 million on hand....)

Now that the swelling in my nuts (and the shrinking of my portfolio) has subsided, I plan to add more EXEL tomorrow.

As Bukowski once said, "it's just business", and to my mind, with the forward looking catalyst and the bundle of cash on hand, the stock is priced to buy.